SEC Comment Letter for CORCEPT THERAPEUTICS INC (CORT) (CIK 0001088856) (CORT) — Aug 24, 2023

CORCEPT THERAPEUTICS INC (CORT) (CIK 0001088856)
Date: Aug. 24, 2023 · CIK: 0001088856 · Accession: 0000000000-23-009319

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-50679

Date

August 24, 2023

Author

Joseph K. Belanoff

Form

UPLOAD

Company

CORCEPT THERAPEUTICS INC (CORT) (CIK 0001088856)

Letter

United States securities and exchange commission logo August 24, 2023 Joseph K. Belanoff Chief Executive Officer Corcept Therapeutics Inc. 149 Commonwealth Drive Menlo Park, CA 94025 Re:Corcept Therapeutics Inc. Definitive Proxy Statement on Schedule 14A Filed April 14, 2023 File No. 000-50679 Dear Joseph K. Belanoff: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Disclosure Review Program

Show Raw Text

United States securities and exchange commission logo
August 24, 2023
Joseph K. Belanoff
Chief Executive Officer
Corcept Therapeutics Inc.
149 Commonwealth Drive
Menlo Park, CA 94025
Re:Corcept Therapeutics Inc.
Definitive Proxy Statement on Schedule 14A
Filed April 14, 2023
File No. 000-50679
Dear Joseph K. Belanoff:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Disclosure Review Program

SecProbe.io